News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
228 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (24660)
Month
January (2721)
February (3480)
March (4381)
April (4039)
May (4871)
June (4841)
July (3188)
August (2609)
September (3140)
October (3520)
November (2936)
December (2392)
Day
1 (220)
4 (220)
5 (268)
6 (267)
7 (261)
8 (228)
11 (232)
12 (283)
13 (269)
14 (282)
15 (266)
16 (1)
18 (253)
19 (277)
20 (235)
21 (232)
22 (169)
26 (226)
27 (233)
28 (241)
29 (208)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
4
5
6
7
8
11
12
13
14
15
16
18
19
20
21
22
26
27
28
29
Drug Development
Novo Nordisk A/S’s Levemir(R) Once-Daily Substantially Lowered Average Blood Sugar Levels of Patients with Type 2 Diabetes in TITRATE(R) Study
May 8, 2009
·
6 min read
Business
Sinovac Biotech Ltd. to Host Conference Call to Report First Quarter 2009 Financial Results
May 8, 2009
·
1 min read
Drug Development
Daiichi Sankyo Co Ltd. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
May 8, 2009
·
9 min read
Drug Development
Daiichi Sankyo Co Ltd. New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure
May 8, 2009
·
10 min read
Drug Development
Daiichi Sankyo Co Ltd. New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure
May 8, 2009
·
12 min read
FDA
Novartis Oncology’s Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery
May 8, 2009
·
7 min read
Business
Alexza Pharmaceuticals, Inc. Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
May 8, 2009
·
9 min read
Business
Exelixis, Inc. to Co-Develop Autoimmune Drugs with Boehringer Ingelheim Corporation; Exelixis Will Receive $15 Million Upfront and Up to $339 Million in Milestone Payments
May 8, 2009
·
6 min read
2010 Launch Of Devgen NV’s Nematicide
May 8, 2009
·
3 min read
Business
Greg Tsongalis Appointed to the AltheaDx Scientific Advisory Board
May 8, 2009
·
2 min read
Previous
19 of 23
Next